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CASE REPORT
A 77-year-old nonsmoker white woman with a medical 
history of mild hypertensive heart disease and diabetes was 
referred to our hospital for diffuse edemas, cough, and persist-
ing asthenia. No history of hemoptysis, loss of weight, loss 
of appetite or other constitutional symptoms was reported. 
A nephrotic syndrome was diagnosed, with massive pro-
teinuria (15–20 g/day), hypoalbuminemia (2.5 g/dl), hyper-
creatininemia (3.4 mg/dl), and associated increase in serum 
lipoprotein levels. Tumor markers (CEA, Ca 19.9, Ca 125, 
NSE, Ca 15.3) were within normal ranges. A renal biopsy 
revealed a status compatible with a stage IV minimal change 
disease. To differentiate the idiopathic versus the secondary 
nature of the nephropathy, a total-body computed tomography 
(CT) scan was performed. An endoluminal lesion measuring 
1.3 cm in the major axis was localized in the right inferior 
lobe (RIL) bronchus (Fig. 1). The positron emission tomog-
raphy (PET)-CT scan (18F-fluorodeoxyglucose/PET-CT) 
characterized the RIL nodule with an standardized uptake 
value (SUV) of 12. No other lesions referable to local or dis-
tant metastases were detected (Fig. 2). A fiber-optic bronchos-
copy revealed an endobronchial red lesion localized near the 
origin of right B6 bronchus. Cytology performed on material 
obtained by endobronchial brushing was suggestive of atypi-
cal cells. Given the relatively high SUV value detected by the 
PET examination and the evidence of cellular atypia at the 
cytological examination, surgery with radical intent was per-
formed, and a right inferior lobectomy plus systematic medi-
astinal lymphadenectomy realized. Final pathology confirmed 
an epithelial tumor characterized by extensive oncocytic fea-
tures, compatible with bronchial oncocytoma (Fig. 3A–E). No 
hilar or mediastinal nodes were involved. The postoperative 
course was uneventful. Four weeks after surgery, serum albu-
min level increased to 3.2 g/dl, creatinine level decreased to 1.8 
mg/dl, and proteinuria decreased to 1.0 g/day. One year after 
surgery, the patient was clinically free of nephropathy and 
cancer recurrence.
DISCUSSION
Oncocytoma is an epithelial tumor and it typically 
occurs in the kidney, salivary glands, and thyroid. In the lit-
erature, oncocytic tumors arising in the lung are rare, and only 
sporadic cases have been reported.1 Although focal oncocytic 
features are commonly observed in carcinoid tumors, carci-
noids consisting almost entirely of oncocytic cells are rela-
tively uncommon.2
In this case, we report final pathology confirmed a 
bronchial oncocytoma, even rarer than oncocytic carcinoid. 
Surprisingly, the preoperative PET-CT scan characterized the 
RIL oncocytoma with a high SUV, in contrast with evidence 
normally reported by other studies.3 Although a case of PET-
positive lung oncocytic carcinoid has been described,4 to the 
best of our knowledge, this is the first case ever reported of 
lung oncocytoma with high SUV at preoperative PET stag-
ing . In particular, the intense uptake on 18F-FDG/PET of the 
oncocytic tumor might be associated with oncocytic compo-
nent. In fact, as previously described by Kadowaki et al.4 the 
overexpression of mitochondria and glucose transporter pro-
tein (Glut)-1 in oncocytic cells is strongly correlated with the 
Bronchial Oncocytoma With High 18F-Fluorodeoxyglucose 
Uptake Revealed by Nephrotic Syndrome
Giovanni Leuzzi, MD,* Alfredo Cesario, MD,*† Marco Chiappetta, MD,* Filippo Lococo, MD,* 
Gianluigi Petrone, MD,‡ Maria Teresa Congedo, MD,* Guido Rindi, PhD,‡ and Pierluigi Granone, PhD*
CASE REPORT
Copyright © 2012 by the International Association for the Study of Lung Cancer
ISSN: 1556-0864/12/0709-e9
*Department of Thoracic Surgery, Catholic University of Sacred Heart, 
Rome, Italy; †Deputy Scientific Director, IRCCS San Raffaele Pisana, 
Rome, Italy; and ‡Department of Pathology, Catholic University of 
Sacred Heart, Rome, Italy.
Disclosure:  The authors declare no conflicts of interest.
Address for correspondence: Giovanni Leuzzi, MD, Department of Thoracic 
Surgery, Catholic University of Sacred Heart, Largo F. Vito n 1, Rome 
00168, Italy. E-mail: gio.leuzzi@yahoo.it 
Journal of Thoracic Oncology
7
9
















e10 Copyright © 2012 by the International Association for the Study of Lung Cancer
Leuzzi et al. Journal of Thoracic Oncology  •  Volume 7, Number 9, September 2012
high 18F-FDG uptake (Fig. 3A–C); however, this mechanism 
is not yet fully understood. 
The second peculiarity of this case is the paraneoplas-
tic glomerulonephritis. This is seldom associated to lung 
cancer and very rarely described in the English literature. 
Furthermore, only few cases correlated to lung carcinoid 
have been reported.5 The case we report of a paraneoplastic 
syndrome associated with a bronchial oncocytoma is, so far, 
the first of its kind ever reported.
In conclusion, the therapeutic strategy we adopted has been 
decided on the basis of the tumor staging and surgery, agreed upon 
as the treatment of choice in the case of paraneoplastic glomeru-
lonephritis,5 has been effective in curing nephropathy. In fact, the 
presence of a paraneoplastic syndrome is not a contraindication, 
FIGURE 2.  The PET-CT scan characterized the endobronchial nodule with an SUV of 12. No local or distant metastases were 
detected. 
FIGURE 3. A, The neoplastic mass within 
the bronchial wall causing compression of 
the bronchial lumen. The tumor exhibited a 
nodular growth pattern (haematoxylin and 
eosin; original magnification × 20). B, The 
tumor was arranged in organoid and tra-
becular clusters separated by thin fibrovas-
cular stroma. Notably, some clusters exhibit 
metaplastic bone formation. Neoplastic cells 
showed a large, eosinophilic, finely granular 
cytoplasm with large, round to oval, vesicu-
lar nuclei with coarse chromatin and small 
nucleoli. The mitotic count was less than 2 
mitosis × 10 high-power fields and no necro-
sis was observed (haematoxylin and eosin; 
original magnification × 200). C. Many of 
the neoplastic cells seemed markedly stained 
for glucose transporter protein in a mem-
brane pattern (haematoxylin counterstain-
ing; original magnification  × 200). D, The 
proliferative index was less than 2% (MIB1/
Ki67) (haematoxylin counterstaining; original 
magnification × 100). E, No immunostaining 
was observed for chromogranin A, synapto-
fisin and CD56-NCAM; some epithelial bron-
chial cells were stained for chromogranin 
A (onset) (Haematoxylin counterstaining; 
original magnification × 100.) 
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unless functional parameters are impaired to the point that sur-
gery itself may be unfeasible.
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